INBICON A/S: Financial statements 2013
CVR: 27036635
Source: annual report 2013, Danish Business Authority
01/01/2013 – 31/12/2013
INBICON A/S (CVR 27036635) has filed annual accounts for 2013. In 2013, the company reported revenue of DKK 16,773,000 and a net result of DKK -68,499,000. The profit margin was -408.4%. Equity in the 2013 report amounted to DKK 44,449,000. The solvency ratio was 47.3%.
- Revenue
- DKK 16,773,000
- Gross Profit
- DKK -84,026,000
- Profit/Loss
- DKK -68,499,000
- Equity
- DKK 44,449,000
- Total Assets
- DKK 93,974,000
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2013
INBICON A/S has published its annual report for 2012.
As of April 24, 2013, Ørsted New Bio Solutions Holding A/S is registered as an owner of INBICON A/S with an ownership share of 100%.
About INBICON A/S
INBICON A/S is a Danish company of the type Aktieselskab based in Fredericia, founded in 2003. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named ELSAM BIOSYSTEMS A/S and KR 354 A/S. The management consists of Thomas Søndergaard Lyse. The board consists of Ole Thomsen (chair), Jens Grymer and Thomas Søndergaard Lyse. The company is owned by Ørsted New Bio Solutions Holding A/S. The company has 0 employees (2011). In 2025, the company reported a net result of DKK -3,447,000 compared with DKK 7,237,000 the year before. Equity in the 2025 report amounted to DKK 35,752,000.